FDA Approved: KRYSTEXXA — Supplemental Application (Horizon Therapeutics USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for KRYSTEXXA (pegloticase) by Horizon Therapeutics USA, Inc., expanding the regulatory authorization for its use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• KRYSTEXXA (pegloticase)

Snippet

SUPPL AP for KRYSTEXXA (PEGLOTICASE)